1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Original Article
You have full text access to this OnlineOpen article
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
Article first published online: 30 DEC 2003
DOI: 10.1002/hep.510260236
Copyright © 1997 by the American Association for the Study of Liver Diseases
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
Additional Information
How to Cite
Bizollon, T., Palazzo, U., Ducerf, C., Chevallier, M., Elliott, M., Baulieux, J., Pouyet, M. and Trepo, C. (1997), Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology, 26: 500–504. doi: 10.1002/hep.510260236
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
References
- 1, , , , , , , et al. Long term follow–up of post–transfusion and sporadic chronic hepatitis non A non B and frequency of circulating antibodies to hepatitis C virus. J Hepatol 1990; 10: 69–76.
- 2, , , , , , , . The course of hepatitis C infection after liver transplantation. Hepatology 1994; 20: 1137–1143.
- 3, , , , , , . Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 1992; 103: 323–324.
- 4, , , , , , . Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994–999.
- 5, , , , , , , et al. Influence of genotype on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1089–1097.
- 6, , , , , , , et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501–1504.
- 7. Variability of hepatitis C virus. Hepatology 1995; 21: 570–583.
- 8. Mechanisms of action of interferon. Semin Liver Dis 1989; 9: 235–239.
- 9, . Molecular mechanism of action of ribavirin. Rev Infect Dis 1990; 12: 1139–1146.
- 10, , , , , , . A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992; 16: 649–654.
- 11, , , . Ribavirin treatment for chronic hepatitis C. Lancet 1991; 337: 1058–1061.
- 12, , , , , . A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 1993; 105: 507–512.
- 13, , , , , , . A pilot study of combination therapy with ribavirin plus Interferon alpha for interferon alpha–resistant chronic hepatitis C. Gastroenterology 1994; 107: 812–817.
- 14, , , . Combined treatment with interferon alpha 2b and ribavirin for chronic hepatitis C in patients with a previous non–response or non–sustained response to interferon alone. J Med Virol 1995; 46: 43–47.
- 15, , , , , , et al. Formulation and application of a numerical scoring system for assessing histological activity in asymtomatic chronic active hepatitis. Hepatology 1981; 1: 431–435.
- 16, , , , , Inchaupse G. Specific detection on hepatitis C virus minus strand RNA in hemato–poitic cells. J Clin Invest 1996; 9: 845–851.
- 17, , . Preliminary experience with α–2b–interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992; 53: 121–124.
- 18, , , , , , . Interferon alpha therapy for hepatitis C virus infection following liver transplantation. Hepatology 1994; 20: 773–779.
- 19, , , , , , , et al. An open trial of IFN alpha recombinant for hepatitis C after liver transplantation. Hepatology 1995; 22: 1084–1089.
- 20, , , , . Alpha–interferon for acute hepatitis in liver transplant patients. Transplant Proc 1995; 27: 1222–1223.
- 21, , , , . Ribavirin therapy for hepatitis C infection following liver transplantation. Transpl Int 1995; 8: 61–64.
- 22, , . Combined inter–feron–alpha 2, rimantadine hydrochloride and ribavirin inhibition of influenza virus replication in vitro. Antimicrob Agents Chemother 1984; 25: 53–57.
- 23, , , , , . Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non–A non–B hepatitis. J Med Virol 1992; 37: 210–214.
- 24, , , , , , . Long–term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C. J Med Virol 1993; 41: 65–70.
- 25, , , . Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver–transplant recipients [Letter]. N Engl J Med 1994; 330: 1161.
- 26, , , . Inhibition of immune functions by antiviral drugs. J Clin Invest 1991; 87: 1916–1924.
- 27, , , , . Long–term skin alograft survival by combined therapy with suboptimal dose of cyclosporin and ribavirin. Transplant Proc 1988; 20: 703–706.